Study of CTX-M Type of Extended Spectrum β-Lactamase among Nosocomial Isolates of Escherichia coli and Klebsiella pneumoniae in South India

被引:0
|
作者
R. Mohamudha Parveen
Subha Manivannan
B. N. Harish
S. C. Parija
机构
[1] Jawaharlal Institute of Post Graduate Medical Education and Research,Department of Microbiology
来源
关键词
Extended spectrum β-lactamase; CTX-M types; Antibiotic resistance; Nosocomial isolates; South India;
D O I
暂无
中图分类号
学科分类号
摘要
Data on CTX-M type extended-spectrum β-lactamase (ESBL) produced by Gram-negative bacteria by molecular methods are limited from India. This study was conducted to investigate the prevalence of CTX-M type ESBL producing Escherichia coli and Klebsiella pneumoniae from nosocomial isolates in a tertiary care hospital in southern India. A total of 179 clinical isolates of K. pneumoniae (n = 72) and E. coli (n = 107) were obtained in a period of 3 months and assessed for ESBL production phenotypically. Associated resistance to a panel of antibiotics and Minimum Inhibitory Concentration for 3rd generation cephalosporins was determined. Phenotypically ESBL positive isolates were subjected to PCR for blaCTX-M gene using two sets of primers for the simultaneous detection of all the five major groups of CTX-M types. All the positive isolates were then subjected to a group specific PCR to detect the prevalent group. Out of 179 isolates, 156 (87.1%) were positive for ESBL phenotypically, which includes 39.2% of K. pneumoniae and 60.8% of E. coli. All of them were examined by PCR using two primers for the presence of blaCTX-M genes. Among the 156 phenotypic positive isolates, 124 (79.4%) were positive for blaCTX-M genes, of which 45 (36.2%) were K. pneumoniae, 79 (63.7%) were E. coli. When the 124 positive clinical isolates were further tested with CTX-M group-specific primers, all were positive for the CTX-M-1 group. Our findings document evidence of the high prevalence of multidrug resistant CTX-M group 1 type ESBL among nosocomial isolates in this region. High co-resistance to other non-β-lactam antibiotics is a major challenge for management of ESBL infections. This is alarming and calls for the judicious use of carbapenems, especially in developing countries. This has significant implications for patient management, and indicates the need for increased surveillance and for further molecular characterization of these isolates.
引用
收藏
页码:35 / 40
页数:5
相关论文
共 50 条
  • [21] CHARACTERIZATION OF SUBTYPES OF CTX-M EXTENDED-SPECTRUM B-LACTAMASE AMONG KLEBSIELLA SPP
    Firoozeh, Farzaneh
    Amiri, Atena
    Moniri, Rezvan
    Zibaei, Mohammad
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2014, 43 : 83 - 83
  • [22] Phenotypic and molecular characterization of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli isolates in Shiraz, Iran
    Zamani, Khosrow
    Emami, Amir
    Bazargani, Abdollah
    Moattari, Afagh
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2015, 48 (04) : 479 - 482
  • [23] Emergence of CTX-M group 1 extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains in the community
    Bedenic, Branka
    Vranes, Jasmina
    Bosnjak, Zrinka
    Marijan, Tatjana
    Mlinaric-Dzepina, Ana
    Kukovec, Tamara
    Knezevic, Jasna
    Anusic, Maja
    Beader, Natasa
    Barl, Petra
    Leskovar, Vladimira
    Kalenic, Smilja
    MEDICINSKI GLASNIK, 2010, 7 (01) : 32 - 39
  • [24] EVALUATION OF EXTENDED SPECTRUM beta-LACTAMASE (ESBL) IN URINARY ISOLATES OF ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE
    Purohit, Manish
    Mutha, Anita
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (01): : 19 - 22
  • [25] Emergence of enterobactefiaceae isolates producing CTX-M extended-spectrum β-lactamase in Austria
    Eisner, A
    Fagan, EJ
    Feierl, G
    Kessler, HH
    Marth, E
    Livermore, DM
    Woodford, N
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 785 - 787
  • [26] CTX-M Type Beta-Lactamase Frequency and Antibiotic Co-resistance in Extended Spectrum Beta-Lactamase Producing Klebsiella pneumoniae Strains
    Nazik, Hasan
    Ongen, Betigul
    Sarikaya, Aysel
    Kuvat, Nuray
    Ilktac, Mehmet
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2011, 31 (02): : 300 - 306
  • [27] Spread of extended-spectrum β-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal
    Mendonca, Nuno
    Leitao, Joana
    Manageiro, Vera
    Ferreira, Eugenia
    Canica, Manuela
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) : 1946 - 1955
  • [28] Identification of Extended-Spectrum-β-Lactamase-Positive Klebsiella pneumoniae Urinary Tract Isolates Harboring KPC and CTX-M β-Lactamases in Nonhospitalized Patients
    Kopacz, Joanna
    Mariano, Noriel
    Colon-Urban, Rita
    Sychangco, Paul
    Wehbeh, Wehbeh
    Segal-Maurer, Sorana
    Urban, Carl
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (10) : 5166 - 5169
  • [29] Risk Factors for Infection or Colonization with CTX-M Extended-Spectrum-β-Lactamase-Positive Escherichia coli
    Han, Jennifer H.
    Kasahara, Kei
    Edelstein, Paul H.
    Bilker, Warren B.
    Lautenbach, Ebbing
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5575 - 5580
  • [30] Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt
    Noha G Khalaf
    Mona M Eletreby
    Nancy D Hanson
    BMC Infectious Diseases, 9